Colorectal Cancer

Latest News

A study conducted by the American Cancer Society found patients who were Black received worse care for colorectal cancer treatment, with health insurance is the leading cause of racial disparities.
Black Population Receives Worse Care Vs White Population for CRC Treatment

November 19th 2023

A study conducted by the American Cancer Society found patients who were Black received worse care for colorectal cancer treatment, with health insurance is the leading cause of racial disparities.

Results from the phase 3 FRESCO-2 trial support the approval of fruquintinib for patients with previously treated metastatic colorectal cancer.
FDA Approves Fruquintinib in Previously Treated Metastatic CRC

November 8th 2023

CHM 2101 will be assessed as part of a phase 1A/B clinical study in a population of patients diagnosed with advanced colorectal cancer, gastric cancer, and neuroendocrine cancer.
FDA Clears NDA for Novel CDH17 CAR T-Cell Therapy in Advanced GI Cancer

November 8th 2023

KRAS/BRAF Testing May Help Define Stage III Colon Cancer Prognosis | Image Credit: © Anatomy Insider - stock.adobe.com.
KRAS/BRAF Testing May Help Define Stage III Colon Cancer Prognosis

November 3rd 2023

Sotorasib plus panitumumab demonstrate consistent efficacy across key patient subgroups with chemorefractory metastatic colorectal cancer harboring KRAS G12C mutations in the phase 3 CodeBreaK 300 trial.
Sotorasib Combo Yields PFS Benefit in KRAS G12C+ Metastatic CRC

October 22nd 2023

Latest CME Events & Activities

Medical Crossfire®: Multidisciplinary Strategies to Leverage Clinical Advances on Immune-Based Therapies for Patients with Hepatocellular Carcinoma

View More

Pathology Oncology Collaborative: Biomarker Testing in an Emerging Era of HER2 Across Breast, GI, and Lung Cancers

View More

2nd Annual Virtual Tumor Board®: Integrating Emerging Testing Methodologies into Optimal Treatment Planning in Gastrointestinal Cancers

View More

Community Practice Connections™: 19th Annual Meeting of the International Society of Gastrointestinal Oncology®

View More

Medical Crossfire®: Antibody-Drug Conjugates Coming to Your Oncology Practice Tomorrow

View More

40th Annual CFS®: Innovative Cancer Therapy for Tomorrow®

View More

Community Practice Connections™: 6th Annual Precision Medicine Through Plasma™ – Using Liquid Biopsies in Contemporary Oncology Care

View More

Equalizing Inequities™ in Multiple Myeloma Care: Shining a Light on Current Barriers and Opportunities for Improved Outcomes

View More

Medical Crossfire®: Critical Questions on Diagnosis, Sequencing, and Selection of Systemic and Radioligand Therapy Options for Patients with GEP-NETs

View More

Community Practice Connections™: 8th Annual School of Gastrointestinal Oncology®

View More

More News